Agios Pharmaceuticals
AGIO
#3497
Rank
NZ$5.39 B
Marketcap
$94.66
Share price
1.68%
Change (1 day)
165.93%
Change (1 year)

Operating Margin for Agios Pharmaceuticals (AGIO)

Operating Margin as of November 2024 (TTM): -1,336.41%

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -1,336.41%. At the end of 2022 the company had an Operating Margin of -1,627.82%.

Operating Margin history for Agios Pharmaceuticals from 2012 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-1,627.82%
2020-161.11%-53.83%
2019-348.97%-4.81%
2018-366.61%-49.89%
2017-731.60%157.64%
2016-283.97%42.59%
2015-199.14%141.34%
2014-82.51%-45.71%
2013-151.98%66.43%
2012-91.32%20.86%
2011-75.56%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-130.01%-90.27%๐Ÿ‡บ๐Ÿ‡ธ USA
28.81%-102.16%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
14.22%-101.06%๐Ÿ‡บ๐Ÿ‡ธ USA
10.36%-100.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
24.84%-101.86%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.